TScan Therapeutics Presents Preliminary Phase 1 Clinical Results on TSC-100 and TSC-101

May 18, 2023

Pyxis Oncology Reports Financial Results for the First Quarter 2023 and Provides Corporate Update

May 12, 2023

Werewolf Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

May 12, 2023

Bicycle rides to 2nd $1.7B Big Pharma deal in 2 months, this time with Bayer

May 11, 2023

Werewolf Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

May 11, 2023

TScan shares soar on news of Amgen deal worth a potential $530M

May 11, 2023